These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33937961)

  • 1. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
    Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
    J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol.
    Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P
    Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
    Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
    APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
    Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
    Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
    Geng D; Song X; Ning F; Song Q; Yin H
    Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.
    Wang X; Wang HK; McCoy JP; Banerjee NS; Rader JS; Broker TR; Meyers C; Chow LT; Zheng ZM
    RNA; 2009 Apr; 15(4):637-47. PubMed ID: 19258450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
    Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
    Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
    Shin MK; Balsitis S; Brake T; Lambert PF
    Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
    Arvizu-Hernandez E; Hernandez-Guerrero CJ; Alvarez-Rios E; Gariglio P; Cornejo-Garrido J; Ocadiz-Delgado R
    J Med Virol; 2024 Apr; 96(4):e29571. PubMed ID: 38563330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a and its novel target, NLRC5, are associated with HPV16 persistence.
    Li J; Yu L; Shen Z; Li Y; Chen B; Wei W; Chen X; Wang Q; Tong F; Lou H; Chu M; Wei L
    Infect Genet Evol; 2016 Oct; 44():293-299. PubMed ID: 27423514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice.
    Gutiérrez J; García-Villa E; Ocadiz-Delgado R; Cortés-Malagón EM; Vázquez J; Roman-Rosales A; Alvarez-Rios E; Celik H; Romano MC; Üren A; Lambert PF; Gariglio P
    Mol Cell Biochem; 2015 Oct; 408(1-2):261-72. PubMed ID: 26173416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.
    Kong Q; Wang W; Li P
    Int J Clin Exp Pathol; 2015; 8(12):15808-13. PubMed ID: 26884851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.
    Ribeiro J; Sousa H
    Mol Biol Rep; 2014 Mar; 41(3):1525-31. PubMed ID: 24402874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression between skin and cervix induced by the E7 oncoprotein in a transgenic mouse model.
    Ibarra Sierra E; Díaz Chávez J; Cortés-Malagón EM; Uribe-Figueroa L; Hidalgo-Miranda A; Lambert PF; Gariglio P
    Virology; 2012 Nov; 433(2):337-45. PubMed ID: 22980503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.
    Cortés-Malagón EM; Bonilla-Delgado J; Díaz-Chávez J; Hidalgo-Miranda A; Romero-Cordoba S; Uren A; Celik H; McCormick M; Munguía-Moreno JA; Ibarra-Sierra E; Escobar-Herrera J; Lambert PF; Mendoza-Villanueva D; Bermudez-Cruz RM; Gariglio P
    Virology; 2013 Dec; 447(1-2):155-65. PubMed ID: 24210110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent Information Regulator 1 Promotes Proliferation, Migration, and Invasion of Cervical Cancer Cells and Is Upregulated by Human Papillomavirus 16 E7 Oncoprotein.
    Wang Y; Wang J; Liu C; Li M
    Gynecol Obstet Invest; 2022; 87(1):22-29. PubMed ID: 34808628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
    Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
    Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.